维普中文期刊产品整合服务
17篇 您的检索式:作者名="Ogert"
    题名 作者 年代 出处 被引量
1Appl Microbiol 显示文摘Ogert RA Brown JR Singh BR 19949 (6): 4891994,9,6:1
2Modification of the CCR5 binding site by mutations in gp 120 influence drug susceptibility and viral infectivity in one subject with clinical resistance to vicriviroc 显示文摘Ogert RA Hou Y Ba L 2009AntivirTher2009,141,:1
3Structure-function analysis of human immunodeficiency virus type 1 gp120 amino acid mutations associated with resistance to the CCR5 coreceptor antagonist Vicriviroc 显示文摘Ogert R A Ba L Hou Y 2009J Virol2009,83,12:1
4Detection of Clostridium botulinum toxin-a using a fiber optic-based biosensor 显示文摘Ogert RA Brown JE Singh BR 1992Anal Biochem1992,205,:1
5Detection of Clostridium botulinum toxin A using a fibre optic-based biosensor显示文摘Ogert R A Brown E J Singh B R 1992Anal Biochem1992,205,306:1
6Detection of Clostridium btulinum toxin A using a fibre optic -based biosensor 显示文摘OGERT R A BROWN E J SINGH B R 1992Anal Biochem1992,,:1
7Detection of Clostridium botulinum toxin A using a fiber optic-based biosensor 显示文摘OGERT R A BROWN J E SINGH B R 1992Anal Biochem1992,205,2:1
8Toxin detection using a fiber optic-based biosensor 显示文摘OGERT R A SHRIVER-LAKE L C LIGLER F S 1993Proc SPIE1993,1885,:1
9Detection of Clostridium botulinum toxin A using a fibre optic-based Biosensor显示文摘Ogert R A Brown J E Singh B R 1992Anal Biochem1992,205,2:1
10Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-I subtype D gpl20 that alter interactions with the N-terminus and ECL2 of CCR5显示文摘Ogert RA Hou Y Ba L Virology0,400,:1
11Structure-function analysis ofhuman immunodeficiency virus type 1gp120amino acid muta-tions associated with resistance to the CCR5coreceptor antag-onist vicriviroc显示文摘Ogert RA Ba L Hou Y 2009J Virol2009,83,12:1
12Resistance - associated amino acid variants associated with boceprevir plus pegyated interferon -2b and ribavirin in patients with chronic hepatitis C in the SPRINT -1 trial 显示文摘OGERT RA HOWE JA VIERLING JM 2013Antivir Ther2013,18,3:1
13Analysis of boceprevir resistance associated amino acid variants(RAVs)in two phase 3 boceprevir clini- cal studies显示文摘Barnard RJ Howe JA Ogert RA 2013Virology2013,444,2:1
14Clinical resistance to vicriviroc through adaptive V3 loop mutations in HIV-I subtype D gpl20 that alter interactions with the N-terminus and ECL2 of CCR5显示文摘Ogert RA Hou Y Ba L 2010Virology2010,400,1:1
15Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies显示文摘Richard J.O. Barnard John A. Howe Robert A. Ogert Stefan Zeuzem Fred Poordad Stuart C. Gordon Robert Ralston Xiao Tong Vilma Sniukiene Julie Strizki Desmond Ryan Jianmin Long Ping Qiu Clifford A. Brass Janice Albrecht Margaret Burroughs Scott Vuocolo Dari 2013Virology . 2013 (1-2)2013,,1:1
16Structure-function analysis of human irnmunodeciency virus type lgp 120 amino acid muta- tions associated to the CCR5 coreptor antagonist vicriviroc显示文摘Ogert RA Ba L Hou Y 2009J Virol2009,83,12:1
17N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism显示文摘Ogert RA Lee MK William Ross W 2001J Virol2001,75,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费